Day: June 18, 2020

CONSTI PLC STOCK EXCHANGE RELEASE 18 JUNE 2020, at 08.00 a.m.The Board of Directors of Consti Plc decided on new stock option planThe Board of Directors of Consti Plc has decided to launch a new key employee stock option plan. There is a weighty financial reason for the Company to issue stock options 2020 since the stock options are intended to form part of the key employee incentive and commitment program of Consti Plc and its subsidiaries. The purpose of the stock options is to encourage the key employees to work on a long-term basis to increase shareholder value. The purpose of the stock options is also to commit the key employees to the employer.The maximum total number of stock options 2020 issued is 245,000 and they entitle their owners to subscribe for a maximum total of 245,000 new shares in the Company or existing shares held...

CONSTI OYJ PÖRSSITIEDOTE 18.6.2020, KLO 08.00Consti Oyj:n hallitus päätti uudesta optio-ohjelmastaConsti Oyj:n hallitus on päättänyt ottaa käyttöön uuden avainhenkilöiden optio-ohjelman. Optio-oikeuksien 2020 antamiselle on yhtiön kannalta painava taloudellinen syy, koska optio-oikeudet on tarkoitettu osaksi Consti Oyj:n ja sen tytäryhtiöiden avainhenkilöiden kannustin- ja sitouttamisjärjestelmää. Optio-oikeuksilla kannustetaan avainhenkilöitä pitkäjänteiseen työntekoon omistaja-arvon kasvattamiseksi. Optio-oikeuksilla pyritään myös sitouttamaan avainhenkilöitä työnantajaan.Optio-oikeuksia 2020 annetaan yhteensä enintään 245 000 kappaletta, ja ne oikeuttavat merkitsemään yhteensä enintään 245 000 yhtiön uutta tai sen hallussa olevaa osaketta. Optio-oikeudet annetaan vastikkeetta.Nyt liikkeeseen laskettavien optio-oikeuksien perusteella...

BRASELTON, Ga., June 17, 2020 (GLOBE NEWSWIRE) — Fox Factory Holding Corp. (NASDAQ: FOXF) (“FOX” or the “Company”) announced today that it has priced its previously announced underwritten public offering of 2,400,000 shares of the Company’s common stock at a public offering price of $76.00 per share, for gross proceeds to the Company of $182,400,000 million, before deducting the underwriting discounts and commissions and other offering expenses. The size of the offering was increased from the previously announced 2,000,000 shares offered.  The Company has granted the underwriters a 30-day option to purchase up to an additional 360,000 shares of its common stock.  The offering is expected to close on or about June 22, 2020, subject to satisfaction of customary closing conditions.BofA Securities is acting as lead book-running manager...

Transaction to Create a Nasdaq-listed Biopharmaceutical Company Focused on Advancing Ocuphire’s Late-Stage Clinical Pipeline of Ophthalmic Drug Candidates$21.15 Million Investment Committed by Institutional Healthcare and Accredited InvestorsROCKVILLE, Md. and FARMINGTON HILLS, Mich., June 17, 2020 (GLOBE NEWSWIRE) — Rexahn Pharmaceuticals, Inc. (NasdaqCM: REXN) and Ocuphire Pharma, Inc., a privately-held clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of eye disorders, today announced the companies have entered into a definitive merger agreement under which Ocuphire will merge with a wholly-owned subsidiary of Rexahn in an all-stock transaction. Following closing, which is expected to occur in the second half of 2020, the combined company will change its...

BOULDER, Colo., June 17, 2020 (GLOBE NEWSWIRE) — Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, today announced the pricing of an underwritten public offering of 17,500,000 shares of common stock or common stock equivalents (which includes pre-funded warrants to purchase shares of common stock in lieu of shares of common stock) and investor warrants to purchase up to an aggregate of 17,500,000 shares of common stock. Each share of common stock (or pre-funded warrant in lieu thereof) is being sold together with one investor warrant to purchase one share of common stock at a combined offering price of $1.15, for total gross proceeds of approximately $20.1 million,...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, June 17, 2020 (GLOBE NEWSWIRE) — Routemaster Capital Inc. (TSXV: RM) (“Routemaster” or the “Company”) Routemaster announces that, further to the press release dated May 4, 2020 it has received an extension from the TSX Venture Exchange (“TSX-V“) with respect to the duration of its previously announced private placement (the “Private Placement“). The outside date upon which final acceptance of the Private Placement will be granted by the TSX-V has been extended to July 18, 2020.About Routemaster Capital Inc.:Routemaster Capital Inc. is a Canadian investment company that carries on business with the objective of enhancing shareholder value. For further information, please contact:Fred LeighPresident and...

CARLSBAD, Calif., June 17, 2020 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSX VENTURE:ASG) announced today that given the extraordinary circumstances of the ongoing COVID-19 pandemic and the resulting restrictions on public gatherings, it is postponing its annual meeting of shareholders to August 11, 2020 in Toronto, Canada.The Company is assessing its options to include telephonic participation with a view to protecting the health and safety of its employees, shareholders, and other usual meeting attendees. As a result, the current meeting and record dates are cancelled. The updated record date is July 6, 2020.Investor Relations EngagementThe Company also announces that it has entered into an agreement with Lytham Partners, LLC (“Lytham“), whereby Lytham will...